PERAMPANEL — TARO, approved 2026-06-15 (ANDA219052).
6,866 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.